- ►critcaremed.org AKM Lipshutz, MA Gropper - Anesthesiology, 2009 - journals.lww.com * Resident, Department of Medicine, Stanford University Medical Center; † Professor and
Vice-Chair, Department of Anesthesia and Perioperative Care, and Director, Critical Care
Medicine, Chair for Medical Quality, University of California, San Francisco. Cited by 16 - Related articles - All 16 versions
BP Kovatchev, M Breton, C Dalla Man, C … - Journal of diabetes …, 2009 - pubmedcentral.nih.gov Arguably, a minimally invasive system using subcutaneous (sc) continuous glucose monitoring
(CGM) and sc insulin delivery via insulin pump would be a most feasible step to closed-loop
control in type 1 diabetes mellitus (T1DM). Consequently, diabetes technology is focusing ... Cited by 4 - Related articles - All 3 versions
CD Saudek - JAMA, 2009 - Am Med Assoc When successful, whole-organ allographic pancreas transplant is a state-of-the-art biological
cure, normalizing blood glucose levels. About 400 to 500 pancreas transplantations are performed
per year in the United States. But how successful is this "cure"? Pancreas transplants ... Cited by 3 - Related articles
J Sherr, E Cengiz, WV Tamborlane - Drug Discovery Today, 2009 - Elsevier Treatment options for pediatric patients living with type 1 diabetes mellitus (T1DM) have drastically
changed over the past 30 years. Technological advances including the development of continuous
subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM) have ... Cited by 1 - Related articles - All 2 versions
KEI MSc, MD Matthew Corcoran, MCR PhD - CANADIAN JOURNAL OF …, 2008 - diabetes.ca Glycemic instability related to exercise in people with type 1 diabetes mellitus is most often studied
using short-term labo- ratory investigation. However, such acute laboratory ses- sions do not
provide an “everyday” depiction of the frequency of blood glucose excursions during ... Cited by 1 - Related articles - View as HTML - All 2 versions
J Sherr, WV Tamborlane - The Mount Sinai journal of medicine, …, 2008 - pubmedcentral.nih.gov With the advent of continuous subcutaneous insulin infusion (CSII) therapy and the findings of
the Diabetes Control and Complications Trial (DCCT) the management of type 1 diabetes has
changed drastically. Over the past 30 years since its development, the effectiveness of ... Cited by 1 - Related articles - All 3 versions
WV Tamborlane, RW Beck - The Lancet, 2009 - Elsevier The first generation of continuous glucose-monitoring systems had suboptimum sensor accuracy
and were either too difficult to use or could only be used for retrospective review. [2] and [3] Accuracy
and usability of real-time monitoring devices has improved such that integration into daily ... Cited by 1 - Related articles - All 18 versions
RP Wadwa, R Fiallo-Scharer, B VanderWel, … - Diabetes Technology …, 2009 - liebertonline.com Abstract Continuous glucose monitoring (CGM) is becoming increasingly popular and represents
the third era of diabetes management. Currently available CGM devices have been studied in
youth with type 1 diabetes and show similar accuracy across all age groups. Tolerability ... Cited by 1 - Related articles - All 3 versions
